J.‐E. Lindgren

1.8k total citations
27 papers, 1.3k citations indexed

About

J.‐E. Lindgren is a scholar working on Pharmacology, Toxicology and Molecular Biology. According to data from OpenAlex, J.‐E. Lindgren has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 7 papers in Toxicology and 5 papers in Molecular Biology. Recurrent topics in J.‐E. Lindgren's work include Cannabis and Cannabinoid Research (12 papers), Forensic Toxicology and Drug Analysis (7 papers) and Psychedelics and Drug Studies (4 papers). J.‐E. Lindgren is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Forensic Toxicology and Drug Analysis (7 papers) and Psychedelics and Drug Studies (4 papers). J.‐E. Lindgren collaborates with scholars based in Sweden, United States and United Kingdom. J.‐E. Lindgren's co-authors include Stig Agurell, Leo E. Hollister, H. K. Gillespie, Annika Ohlsson, A. Wahlén, M Widman, Magnus M. Halldin, Bo Holmstedt, A Ohlsson and Ulf G. Ahlborg and has published in prestigious journals such as Science, FEBS Letters and Pharmacological Reviews.

In The Last Decade

J.‐E. Lindgren

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.‐E. Lindgren Sweden 15 937 387 291 181 144 27 1.3k
H. K. Gillespie United States 16 1.4k 1.5× 695 1.8× 403 1.4× 228 1.3× 274 1.9× 22 1.7k
Dolores R. Brine United States 16 634 0.7× 295 0.8× 306 1.1× 91 0.5× 47 0.3× 27 1.1k
G. Kauert Germany 16 1.1k 1.2× 341 0.9× 613 2.1× 168 0.9× 190 1.3× 47 1.6k
Magnus M. Halldin Sweden 18 713 0.8× 264 0.7× 289 1.0× 69 0.4× 69 0.5× 50 1.3k
M Widman Sweden 14 520 0.6× 227 0.6× 178 0.6× 54 0.3× 61 0.4× 31 739
A. Wahlén Sweden 9 537 0.6× 241 0.6× 192 0.7× 63 0.3× 91 0.6× 12 745
Kenneth H. Davis United States 13 525 0.6× 225 0.6× 215 0.7× 71 0.4× 43 0.3× 21 732
Mario Perez‐Reyes United States 27 1.4k 1.5× 1.1k 2.8× 1.0k 3.5× 290 1.6× 269 1.9× 51 2.7k
Hollister Le United States 15 491 0.5× 453 1.2× 84 0.3× 97 0.5× 148 1.0× 67 1.1k
N. Lander Israel 11 784 0.8× 421 1.1× 125 0.4× 99 0.5× 135 0.9× 20 948

Countries citing papers authored by J.‐E. Lindgren

Since Specialization
Citations

This map shows the geographic impact of J.‐E. Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐E. Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐E. Lindgren more than expected).

Fields of papers citing papers by J.‐E. Lindgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐E. Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐E. Lindgren. The network helps show where J.‐E. Lindgren may publish in the future.

Co-authorship network of co-authors of J.‐E. Lindgren

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐E. Lindgren. A scholar is included among the top collaborators of J.‐E. Lindgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐E. Lindgren. J.‐E. Lindgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breuer, Olof, et al.. (1998). Pharmacokinetics of robalzotan in rats and dogs including in vitro and in vivo data on metabolism. European Neuropsychopharmacology. 8. S185–S185. 3 indexed citations
2.
Lundström, Jan O., J.‐E. Lindgren, S. Ahlenius, & Viveka Hillegaart. (1992). Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.. Journal of Pharmacology and Experimental Therapeutics. 262(1). 41–47. 7 indexed citations
3.
Agurell, Stig, Magnus M. Halldin, J.‐E. Lindgren, et al.. (1986). Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.. Pharmacological Reviews. 38(1). 21–43. 304 indexed citations
4.
Gillespie, H. K., Magnus M. Halldin, Leo E. Hollister, et al.. (1985). review of recent studies on the pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol, cannabidiol and cannabinol in man. 4 indexed citations
5.
Lindgren, J.‐E.. (1983). Quantification of Δ 1-Tetrahydrocannabinol in Tissues and Body Fluids. Archives of toxicology. Supplement. 6. 74–80. 1 indexed citations
6.
Lindgren, J.‐E. & Bo Holmstedt. (1983). Guide to the Analysis of Phencyclidine and its Metabolites in Biological Material. Archives of toxicology. Supplement. 6. 61–73. 1 indexed citations
7.
Halldin, Magnus M., M Widman, Christer von Bahr, J.‐E. Lindgren, & Billy R. Martin. (1982). Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.. Drug Metabolism and Disposition. 10(4). 297–301. 32 indexed citations
8.
9.
Hollister, Leo E., H. K. Gillespie, Annika Ohlsson, et al.. (1981). Do Plasma Concentrations of Δ9‐Tetrahydrocannabinol Reflect the Degree of Intoxication?. The Journal of Clinical Pharmacology. 21(S1). 171S–177S. 123 indexed citations
10.
Agurell, Stig, J.‐E. Lindgren, & A Ohlsson. (1979). INTRODUCTION TO QUANTIFICATION OF CANNABINOIDS AND THEIR METABOLITES IN BIOLOGICAL FLUIDS. Elsevier eBooks. 22-23. 3–13. 4 indexed citations
11.
Yisak, W., Stig Agurell, J.‐E. Lindgren, & M Widman. (1978). In vivo metabolites of cannabinol identified as fatty acid conjugates. Journal of Pharmacy and Pharmacology. 30(1). 462–464. 16 indexed citations
12.
Jostell, K.‐G., Stig Agurell, Lars‐Göran Allgén, et al.. (1978). Pharmacokinetics of Clomethiazole in Healthy Adults. Acta Pharmacologica et Toxicologica. 43(3). 180–189. 26 indexed citations
13.
Levander, Sten, et al.. (1974). Proceedings: Pharmacokinetics in relation to physiological and psychological effects of delta-8-THC.. PubMed. 11(6). 662–3. 3 indexed citations
14.
Agurell, Stig, et al.. (1974). Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography. Journal of Pharmacy and Pharmacology. 26(1). 1–8. 34 indexed citations
15.
Alv�n, G., et al.. (1974). Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. European Journal of Clinical Pharmacology. 7(6). 449–454. 26 indexed citations
16.
Ahlborg, Ulf G., et al.. (1974). Metabolism of pentachlorophenol. Archives of Toxicology. 32(4). 271–281. 71 indexed citations
17.
Lindgren, J.‐E., Stig Agurell, Jan O. Lundström, & U Svensson. (1971). Detection of biochemical intermediates by mass fragmentography: Mescaline and tetrahydroisoquinoline precursors. FEBS Letters. 13(1). 21–27. 6 indexed citations
18.
Holmstedt, Bo, et al.. (1969). Metabolism of 5-methoxy-N,N dimethyltryptamine-14C in the rat. Biochemical Pharmacology. 18(12). 2771–2781. 29 indexed citations
19.
Agurell, Stig, Bo Holmstedt, J.‐E. Lindgren, & Richard Evans Schultes. (1968). Identification of two new β-carboline alkaloids in South American hallucinogenic plants. Biochemical Pharmacology. 17(12). 2487–2488. 28 indexed citations
20.
Holmstedt, Bo & J.‐E. Lindgren. (1967). Ayahuasca, caapi, yage. Psychotropic properties of the harmala alkaloids.. PubMed. 4(3). 16–16. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. K. Gillespie Breakdown of academic impact, for papers by Dolores R. Brine Breakdown of academic impact, for papers by G. Kauert Breakdown of academic impact, for papers by Magnus M. Halldin Breakdown of academic impact, for papers by M Widman Breakdown of academic impact, for papers by A. Wahlén Breakdown of academic impact, for papers by Kenneth H. Davis Breakdown of academic impact, for papers by Mario Perez‐Reyes Breakdown of academic impact, for papers by Hollister Le Breakdown of academic impact, for papers by N. Lander
Rankless by CCL
2026